Drug Profile
Research programme: influenza virus vaccines - ROVI
Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Rovi
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 08 Feb 2010 Discontinued for Influenza virus infections in Spain (unspecified route)
- 02 Jul 2009 Early research in Influenza virus infections in Spain (unspecified route)